Pancreatic Cancer Research

ResearcherYonsei UniversityActive in the last 2 years

Hwa-Ryeon Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9418-7061; OpenAlex author ID A5027392687. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 3

  1. Mutant p53 regulates reversible subtype plasticity in pancreatic cancer. First author DOI 10.1007/s00018-025-05945-w↗
  2. A TEAD2-Driven Endothelial-Like Program Shapes Basal-Like Differentiation and Metastasis of Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2023.02.049↗
  3. EVI1 activates tumor-promoting transcriptional enhancers in pancreatic cancer. Co-author DOI 10.1093/narcan/zcab023↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jae‐Seok Roe · 3 shared papers, 2021–2025 · strength 0.69
  2. June-Ha Shin · 1 shared paper, 2025 · strength 0.42
  3. Hye-Been Yoo · 2 shared papers, 2021–2023 · strength 0.26
  4. Sabrina Ge · 1 shared paper, 2023 · strength 0.15
  5. Hee Seung Lee · 1 shared paper, 2023 · strength 0.15
  6. Koji Miyabayashi · 1 shared paper, 2023 · strength 0.15
  7. Faiyaz Notta · 1 shared paper, 2023 · strength 0.15
  8. Seungmin Bang · 1 shared paper, 2023 · strength 0.15
  9. David Arthur Tuveson · 1 shared paper, 2023 · strength 0.15
  10. Chang‐Il Hwang · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.